1. Home
  2. FSBC vs TBPH Comparison

FSBC vs TBPH Comparison

Compare FSBC & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Star Bancorp

FSBC

Five Star Bancorp

HOLD

Current Price

$41.96

Market Cap

860.4M

Sector

Finance

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.40

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBC
TBPH
Founded
2002
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
860.4M
824.9M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
FSBC
TBPH
Price
$41.96
$16.40
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$41.90
$18.40
AVG Volume (30 Days)
74.7K
282.6K
Earning Date
04-27-2026
05-04-2026
Dividend Yield
2.47%
N/A
EPS Growth
28.32
279.13
EPS
0.87
N/A
Revenue
N/A
$15,386,000.00
Revenue This Year
$30.25
$8.46
Revenue Next Year
$12.30
N/A
P/E Ratio
$48.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.26
$9.10
52 Week High
$42.26
$21.03

Technical Indicators

Market Signals
Indicator
FSBC
TBPH
Relative Strength Index (RSI) 60.54 46.74
Support Level $39.93 $16.14
Resistance Level N/A $17.21
Average True Range (ATR) 1.00 0.38
MACD 0.03 -0.07
Stochastic Oscillator 78.74 29.31

Price Performance

Historical Comparison
FSBC
TBPH

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company that operates in California through its subsidiary, a state-chartered non-member bank. The company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans, and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment: Banking.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: